GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

While we have commonly heard of common side effects of weight loss jabs such as nausea and constipation, there is a new concern that experts are highlighting and users are discussing across support ...

Scientists have gene-hacked mice to produce their own Ozempic-like drugs, paving a path for humans to do so themselves one ...

More scientific evidence is emerging to show that our gastrointestinal system interacts with our nervous system ...

A national survey found low use of weight loss drugs for MASLD despite widespread belief in their benefits. A study published in June 2025 issue of Journal of Clinical Gastroenterology highlighted the ...

News in the nutraceutical sector. Ettore Novellino, an Irpinian researcher and former dean of the Department of Pharmacy at ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Regarding injection site rotation, alternate between different areas like the abdomen, thigh, or upper arm to prevent ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Constantly being hungry isn’t normal—but experts say there are natural appetite suppressants that can keep your cravings ...